Cargando…

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia

BACKGROUND: Many countries are transitioning from cytology-based to longer-interval HPV screening. Trials comparing HPV-based screening to cytology report an increase in CIN2/3 detection at the first screen, and longer-term reductions in CIN3+; however, population level year-to-year transitional imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Michaela T., Simms, Kate T., Lew, Jie-Bin, Smith, Megan A., Saville, Marion, Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812553/ https://www.ncbi.nlm.nih.gov/pubmed/29444073 http://dx.doi.org/10.1371/journal.pone.0185332

Ejemplares similares

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035
por: Youlden, Danny R, et al.
Publicado: (2019)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
por: Canfell, Karen, et al.
Publicado: (2019)

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
por: Canfell, Karen, et al.
Publicado: (2021)

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea
por: Nguyen, Diep Thi Ngoc, et al.
Publicado: (2022)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
por: Nickson, Carolyn, et al.
Publicado: (2023)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Development and application of a framework to estimate health care costs in China: The cervical cancer example
por: Liu, Yi-Jun, et al.
Publicado: (2019)

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake
por: Smith, Megan A., et al.
Publicado: (2014)

Progress in eliminating HPV-associated disease
por: Stern, Peter L., et al.
Publicado: (2019)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
por: Smith, Megan A., et al.
Publicado: (2016)

Cancer incidence and mortality projections in the UK until 2035
por: Smittenaar, C R, et al.
Publicado: (2016)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Global trajectories of liver cancer burden from 1990 to 2019 and projection to 2035
por: Yang, Fan, et al.
Publicado: (2023)

Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women
por: Ju, Xiangqun, et al.
Publicado: (2021)

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
por: Gertig, Dorota M, et al.
Publicado: (2013)

The burden of gastrointestinal diseases in Japan, 1990–2019, and projections for 2035
por: Shiratori, Yasutoshi, et al.
Publicado: (2023)

Trends in cigarette consumption across the United States, with projections to 2035
por: Leas, Eric C., et al.
Publicado: (2023)

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
por: Creighton, Prudence, et al.
Publicado: (2010)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods
por: Miyoshi, Ai, et al.
Publicado: (2020)

The involvement of HPV in cervical oncogenesis
por: Mitran, Mihai, et al.
Publicado: (2013)

Science publishing 2035
por: Higgitt, Rebekah
Publicado: (2016)

The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study
por: Bavor, Claire, et al.
Publicado: (2023)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review
por: Sethi, Sneha, et al.
Publicado: (2021)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
por: Senkomago, Virginia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2cltugmlqln8tpnh36tffq0m4e